Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.

Lignende værker

• Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
  af: Croucher, P, et al.
  Udgivet: (2003)
• Osteoprotegerin and the development of myeloma bone disease
  af: Croucher, P, et al.
  Udgivet: (2004)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
  af: Croucher, P, et al.
  Udgivet: (2001)
• Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
  af: De Leenheer, E, et al.
  Udgivet: (2004)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
  af: Croucher, P, et al.
  Udgivet: (2001)